BCAB today
$1.74-$1.41 (-44.75%)close Aug 28, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourLeaning Bearish
15 minLeaning Bullish
5 minNo data
Daily trend turns up above $3.71
Key levels
Resistance$3.52
Resistance$2.81
Latest news & SEC filings
SEC FilingBioAtla, Inc. filed a registration statement for new shares (Form S-1)
SEC FilingBioAtla, Inc. filed a report on a major company event (Form 8-K)
All BCAB news →OTC · Healthcare
BioAtla, Inc. (BCAB)
What Is the Price Target for BCAB?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is BCAB a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BCAB.
Start Free Trial →Is BCAB Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
PEG
Fair Value
$333.39
34
Moat Score
NONE
1/9
Piotroski Score
-68.0
Altman Z-Score
What Is Smart Money Doing with BCAB?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| SHORT JAY M PHD | director officer | Sale | 259 | $437.71 | Aug 31, 2026 |
| Sievers Eric | officer | Sale | 134 | $226.46 | Aug 31, 2026 |
| Vasquez Christian | officer | Sale | 71 | $119.99 | Aug 31, 2026 |
| SHORT JAY M PHD | director officer | Sale | 259 | $1K | May 31, 2026 |
| Vasquez Christian | officer | Sale | 82 | $322.26 | May 31, 2026 |
| Sievers Eric | officer | Sale | 134 | $526.62 | May 31, 2026 |
| SHORT JAY M PHD | director officer | Sale | 639 | $107.35 | Mar 12, 2026 |
| Vasquez Christian | officer | Sale | 175 | $29.58 | Mar 11, 2026 |
| Sievers Eric | officer | Sale | 360 | $60.84 | Mar 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BCAB Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
29.86%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for BCAB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BCAB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:11:11 | $1.60 | 1,300 | $$2K | BUY |
| 20:19:25 | $1.70 | 1,300 | $$2K | BUY |
| 20:05:03 | $1.73 | 1,000 | $$2K | SELL |
| 20:05:03 | $1.73 | 1,300 | $$2K | SELL |
| 19:59:03 | $1.78 | 1,300 | $$2K | BUY |
5 dark pool trades shown · $$11K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for BioAtla, Inc. (BCAB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BCAB — frequently asked questions
What is BCAB stock price today?
BioAtla, Inc. (BCAB) is at $1.74, down 44.75% (-$1.41) at the Aug 28, 2026 close.
Why is BCAB stock moving today?
Latest BCAB news — Oct 19, 2026: BioAtla, Inc. filed a registration statement for new shares (Form S-1) · Oct 19, 2026: BioAtla, Inc. filed a report on a major company event (Form 8-K)
Did BCAB beat earnings?
BCAB last reported on Aug 13, 2026: EPS $0.27 vs -$8.50 expected — a beat of 103.2%.
Does BCAB pay a dividend?
BCAB does not currently pay a dividend.
What are BCAB support and resistance levels?
Resistance: $2.81, $3.52, $4.00.
What are insiders doing with BCAB?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BCAB?
Oct 19, 2026: BioAtla, Inc. filed a registration statement for new shares (Form S-1) · Oct 19, 2026: BioAtla, Inc. filed a report on a major company event (Form 8-K)